Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Mazen S. Zenati"'
Autor:
Amer H. Zureikat, Mordechai Rabinowitz, Herbert J. Zeh, Savreet Sarkaria, Melissa E. Hogg, Georgios I. Papachristou, John Nasr, Kenneth K. Lee, Jennifer Chennat, Wolfgang H. Schraut, Mazen S. Zenati, Steve J. Hughes, Adam Slivka, Michael K. Sanders, Andres Gelrud, Rohit Das, A. James Moser, Asif Khalid, Alessandro Paniccia, Samer AlMasri
Publikováno v:
Surgical Endoscopy. 36:621-630
Treatment of pancreaticobiliary pathology following Roux-en-Y gastric bypass (RYGB) poses significant technical challenges. Laparoscopic-assisted endoscopic retrograde cholangiopancreatography (LA-ERCP) can overcome those anatomical hurdles, allowing
Autor:
James A. Brown, Richard L. Simmons, Amer H. Zureikat, Mazen S. Zenati, Melissa E. Hogg, Jae P. Jung, Amr I. Al Abbas, Herbert J. Zeh
Publikováno v:
HPB. 23:144-153
Background Cholangitis due to anastomotic stricture of the hepaticojejunostomy (HJ) following pancreaticoduodenectomy (PD), while uncommon, adversely affects postoperative quality-of-life. While prior studies have identified patient-related risk fact
Autor:
Brian A. Boone, Joal D. Beane, Mazen S. Zenati, Herbert J. Zeh, A. James Moser, Melissa E. Hogg, David L. Bartlett, Amr I. Al Abbas, Amer H. Zureikat
Publikováno v:
Ann Surg
OBJECTIVES: This study aims to present the outcomes of our decade-long experience of robotic pancreatoduodenectomy and provide insights into successful program implementation. BACKGROUND: Despite significant improvement inmortality over the past 30 y
Autor:
Amr Al-abbas, Melissa E. Hogg, Caroline J. Rieser, Matthew D. Neal, Amer H. Zureikat, Mazen S. Zenati, Brian A. Boone, Ahmad Hamad, Herbert J. Zeh
Publikováno v:
Annals of Surgical Oncology. 26:1503-1511
Pancreatic ductal adenocarcinoma (PDA) is associated with a hypercoagulable state, resulting in a high risk of venous thromboembolism (VTE). Risk of VTE is well established for patients receiving chemotherapy for advanced disease and during the perio
Autor:
Melissa E. Hogg, Amer H. Zureikat, Mazen S. Zenati, Mark D. Girgis, Ahmad Hamad, Jonathan C. King, Herbert J. Zeh
Publikováno v:
Annals of surgery. 274(3)
OBJECTIVE Compare oncologic outcomes after open and robotic pancreatic resections for pancreatic adenocarcinoma (PDAC). SUMMARY OF BACKGROUND DATA Receipt of adjuvant chemotherapy improves survival after resected PDAC. Complications after pancreatect
Autor:
Nathan Bahary, Caroline J. Rieser, Herbert J. Zeh, Mazen S. Zenati, Kenneth K. Lee, Amer H. Zureikat, Hao Liu, Aatur D. Singhi, Amr Al-abbas, Melissa E. Hogg
Publikováno v:
Ann Surg Oncol
BACKGROUND: Neoadjuvant therapy (NAT) is increasingly utilized for pancreatic cancer, however the added benefit of adjuvant therapy (AT) in this setting is unknown. We hypothesized that the magnitude of CA19-9 response to NAT can guide the need for f
Autor:
Matthew P. Holtzman, Amer H. Zureikat, Melanie Ongchin, David L Bartlett, Caroline J. Rieser, James F. Pingpank, Andrew Lee, Mazen S. Zenati, M. Haroon A. Choudry, Richard S. Hoehn, Eliza Kang, Lauren B Hall
Publikováno v:
Annals of Surgical Oncology. 28:875-875
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS HIPEC) can offer significant survival advantage for select patients with colorectal peritoneal metastases (CRPM). Low socioeconomic status (SES) is implicated in disparities i
Autor:
Jennifer Steve, Herbert J. Zeh, Mazen S. Zenati, Amer H. Zureikat, David L. Bartlett, Mark D. Girgis, Melissa E. Hogg
Publikováno v:
HPB. 19:93-98
The aim was to evaluate the impact of obesity on perioperative outcomes in patients undergoing robotic pancreaticoduodenectomy (RPD) compared to open pancreaticoduodenectomy (OPD).A retrospective review of all pancreaticoduodenectomies from 9/2011 to
Autor:
Jennifer Steve, Heather L. Jones, Mazen S. Zenati, Samantha Perkins, James F. Pingpank, Melissa E. Hogg, Haroon A. Choudry, Herbert J. Zeh, David L. Bartlett, Mashaal Dhir, Amber K. Clifford, Matthew P. Holtzman, Amer H. Zureikat, James C. Padussis
Publikováno v:
Journal of Surgical Oncology. 114:342-347
Background Hepatic artery infusion (HAI) chemotherapy can be combined with systemic chemotherapy for the treatment of isolated unresectable colorectal liver metastases (IU-CRLM) and intrahepatic cholangiocarcinoma (U-ICC). However, HAI pump placement
Autor:
Pranav Murthy, Amr I. Al Abbas, Mazen S. Zenati, Nathan Bahary, Michael T. Lotze, Amer H. Zureikat, Brian A. Boone, Caroline J. Rieser, Herbert J. Zeh
Publikováno v:
Ann Surg Oncol
BACKGROUND. The systemic immune-inflammation index (SII), calculated using absolute platelet, neutrophil, and lymphocyte counts, has recently emerged as a predictor of survival for patients with pancreatic ductal adenocarcinoma (PDAC) when assessed a